- Home
- ISRG vs ABT Comparison
ISRG vs ABT Comparison
Compare ISRG & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISRG
- ABT
- Stock Information
- Founded
- ISRG 1995
- ABT 1888
- Country
- ISRG United States
- ABT United States
- Employees
- ISRG N/A
- ABT N/A
- Industry
- ISRG Medical/Dental Instruments
- ABT Medical/Dental Instruments
- Sector
- ISRG Health Care
- ABT Health Care
- Exchange
- ISRG Nasdaq
- ABT Nasdaq
- Market Cap
- ISRG 200.0B
- ABT 237.4B
- IPO Year
- ISRG 2000
- ABT N/A
- Fundamental
- Price
- ISRG $512.06
- ABT $131.99
- Analyst Decision
- ISRG Buy
- ABT Buy
- Analyst Count
- ISRG 18
- ABT 18
- Target Price
- ISRG $588.18
- ABT $141.61
- AVG Volume (30 Days)
- ISRG 1.6M
- ABT 5.9M
- Earning Date
- ISRG 07-22-2025
- ABT 07-17-2025
- Dividend Yield
- ISRG N/A
- ABT 1.79%
- EPS Growth
- ISRG 23.31
- ABT 139.92
- EPS
- ISRG 6.83
- ABT 7.70
- Revenue
- ISRG $8,714,900,000.00
- ABT $42,344,000,000.00
- Revenue This Year
- ISRG $17.89
- ABT $7.56
- Revenue Next Year
- ISRG $15.14
- ABT $7.73
- P/E Ratio
- ISRG $74.96
- ABT $17.14
- Revenue Growth
- ISRG 19.08
- ABT 5.00
- 52 Week Low
- ISRG $413.82
- ABT $99.71
- 52 Week High
- ISRG $616.00
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- ISRG 38.31
- ABT 43.23
- Support Level
- ISRG $531.67
- ABT $131.47
- Resistance Level
- ISRG $550.70
- ABT $135.05
- Average True Range (ATR)
- ISRG 11.28
- ABT 2.63
- MACD
- ISRG -0.96
- ABT -0.38
- Stochastic Oscillator
- ISRG 18.69
- ABT 9.24
About ISRG Intuitive Surgical Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.